Skip to content
AnalystLens

AMPHENOL CORP /DE/ 8-K Report, Financial Results (Apr 23, 2025)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed April 23, 2025
Period End
April 23, 2025
Security
APH
In the record · 2016–202610-K1110-Q328-K138

APH filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 138 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Apr ’17Apr ’17
  2. Material agreement8-K · May ’20May ’20
  3. Leadership change8-K · Jan ’23Jan ’23
  4. Leadership change8-K · Oct ’26Oct ’26

01—Abstract

Summary

Summary of the 8-K filed April 23, 2025. Cited figures are marked; the original filing is the authoritative source.

Amphenol (APH) reported record first-quarter 2025 results on April 23, 2025, with net sales of $4.81 billiona, up 48% in U.S. dollars and 33% organically versus Q1 2024.

GAAP diluted EPS was $0.58b (up 32%), while record Adjusted Diluted EPS was $0.63 (up 58%). Adjusted Operating Margin reached a record 23.5% against a GAAP operating margin of 21.3%. Growth was driven by strong organic gains in IT datacom, mobile devices, defense and communications networks, plus contributions from acquisitions.

Communications Solutions was the standout segment, with sales up 91% and operating margin expanding to 27.4%. Cash generation and capital returns remained strong. Operating cash flow was $765 millionc and free cash flow was $580 million.

During the quarter Amphenol repurchased 2.7 million shares for $180.9 milliond and paid $200 million in dividends, returning roughly $380 million to shareholders. The company closed the LifeSync acquisition and the CommScope OWN and DAS businesses (now called Andrew), which required about $2.17 billion in cash. Interest expense rose to $76.5 million from $38.1 million, and total debt increased, so the balance sheet is more leveraged than a year earlier, though cash remains solid at $1.67 billion.

Looking ahead, management guided Q2 2025 sales to $4.90–$5.00 billion (up 36–39%) and Adjusted Diluted EPS to $0.64–$0.66 (up 45–50%), assuming current market conditions and constant exchange rates. Management also raised the expected 2025 accretion from the Andrew acquisition to about $0.09 from $0.06.

It cautioned that the economic and geopolitical environment remains uncertain. Investors should weigh the strong operating momentum against the reported-to-adjusted EPS gap, which includes $0.06 of acquisition-related expenses, and against the pace of integration and acquisition-driven growth.

02—Key points

Key Highlights

  1. Record Q1 2025 net sales of $4.81B, up 48% in USD and 33% organically, with Communications Solutions up 91%.
  2. Record Adjusted Diluted EPS of $0.63 (up 58%) versus GAAP diluted EPS of $0.58 (up 32%); the gap reflects roughly $0.06 of acquisition-related expenses and $0.04 of inventory step-up amortization.
  3. Record Adjusted Operating Margin of 23.5% versus GAAP operating margin of 21.3%; Communications Solutions margin rose to 27.4% from 22.6%.
  4. Operating cash flow of $765M and free cash flow of $580M (up from $506M a year earlier).
  5. Returned about $380M to shareholders in Q1 through $180.9M of buybacks (2.7M shares) and $200M of dividends.
  6. Closed the LifeSync and CommScope OWN/DAS (Andrew) acquisitions; Andrew accretion to 2025 Adjusted EPS raised to about $0.09 from $0.06.
  7. Q2 2025 guidance of $4.90–$5.00B in sales (up 36–39%) and $0.64–$0.66 Adjusted Diluted EPS (up 45–50%), with management flagging continued macro and geopolitical uncertainty.

03—Questions

Frequently Asked Questions

  1. What were Amphenol's key Q1 2025 results?

    Net sales were a record $4.81 billion, up 48% in U.S. dollars and 33% organically. GAAP diluted EPS was $0.58, and record Adjusted Diluted EPS was $0.63. Operating cash flow was $765 million and free cash flow was $580 million.

  2. Why is there a gap between GAAP and Adjusted EPS?

    The company excludes items not tied to core operating performance. In Q1 2025 these included about $104.9 million of acquisition-related expenses ($0.06 per share) and $60.9 million of inventory step-up amortization ($0.04 per share) from the Andrew acquisition. Excess tax benefits from stock-based compensation ($0.02 per share) were also excluded.

  3. What is the outlook for Q2 2025?

    Management expects Q2 2025 net sales of $4.90–$5.00 billion, up 36–39% year over year, and Adjusted Diluted EPS of $0.64–$0.66, up 45–50%. Guidance assumes current market conditions and constant exchange rates. GAAP diluted EPS is guided to $0.63–$0.65.

  4. How did the acquisitions affect the company?

    Amphenol closed LifeSync and CommScope's OWN and DAS businesses (Andrew) in Q1 2025, spending about $2.17 billion in cash. Management raised the expected 2025 Adjusted EPS accretion from Andrew to about $0.09, from $0.06. Acquisitions also drove a large part of the reported sales growth and increased goodwill and intangibles.

  5. What are the main risks to watch?

    Key risks include macroeconomic and geopolitical uncertainty, trade policy and tariffs, cyclical end-market demand, integration of acquired businesses, and rising interest expense (up to $76.5 million from $38.1 million) as debt rose to about $7.2 billion. Management also highlighted raw material cost pressures and foreign currency exposure.

04—Continue

← View all 8-K filings